Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
Completed · Not applicable
Conditions studied: HIV, Acquired Immunodeficiency Syndrome, Cardiovascular Diseases
In brief
People infected with HIV are now living longer lives because of the use of highly active antiretroviral therapy (HAART). However, HAART medications have been shown to increase the risk of cardiovascular disease and metabolic dysfunction in adults. More research is needed on the effect of HAART in children. The purpose of this study is to assess cardiovascular risk factors in children infected with HIV who receive HAART medications and to determine the effectiveness of an exercise program on cardiovascular outcomes in these children.
Key facts
- Study ID
- NCT00908284
- Run by
- University of Miami
- People needed
- 16
- Starts
- 2008-12-01
- Expected to finish
- 2015-11-01
- Last updated by the study team
- 2015-12-07
Who can join
Age: 0 and older, up to 25. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Miami, Department of Pediatrics, Division of Clinical Research, Batchelor Children's Research Institute — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.